caa a22 4500 388034335 CHVBK 20180307125000.0 cr unu---uuuuu 161130e199808 xx s 000 0 eng 10.1086/647871 doi S0195941700088354 pii (NATIONALLICENCE)cambridge-10.1086/647871 Goossens Herman Department of Microbiology, University Hospital Antwerp, Edegem-Antwerp, Belgium Spread of Vancomycin-Resistant Enterococci: Differences Between the United States and Europe [Elektronische Daten] [Herman Goossens] There are major differences in the epidemiology of vancomycin-resistant enterococci (VRE) between the United States and Europe. In contrast with Europe, VRE in the United States are resistant to many antibiotics, and there appears to be less genetic variability among these isolates. European VRE of human origin are usually susceptible to many other antibiotics and are highly polyclonal. These clinical isolates have the same susceptibility profiles as VRE isolated from animals. The differences in the spread of VRE between the United States and Europe might be explained by the overconsumption of glycopeptides and other antibiotics in hospitals in the United States and the use of avoparcin as a growth promotor in Europe. Copyright © The Society for Healthcare Epidemiology of America 1998 Infection Control & Hospital Epidemiology Cambridge University Press 19/8(1998-08), 546-551 0899-823X 19:8<546 1998 19 ICE https://doi.org/10.1086/647871 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1086/647871 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Goossens Herman Department of Microbiology, University Hospital Antwerp, Edegem-Antwerp, Belgium NATIONALLICENCE 773 0- Infection Control & Hospital Epidemiology Cambridge University Press 19/8(1998-08), 546-551 0899-823X 19:8<546 1998 19 ICE CC0 http://creativecommons.org/publicdomain/zero/1.0 nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-cambridge